Most adverse events in the combination group were attributed to lenvatinib and could be managed by dose reduction or symptomatic treatment.

Clinically significant cancer was detected in 29.2 versus 29.6 percent of men with biparametric and multiparametric MRI.

Given the potential for volatility in future cancer research and global health funding from the USA due to federal funding cuts, there might be increased strategic value in other countries ...

Researchers examined potential differences in the risk factor profiles of nevus-associated vs de novo melanoma.

Researchers conducted a retrospective cohort study to assess the features associated with disease persistence among pediatric patients with thyroid cancer.

A pilot study sought to measure the impact of Program CONNECT on the confidence, knowledge, and skills of health professional trainees to navigate patients through lung cancer screening.